Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)
4.580
+0.100 (2.23%)
Jul 10, 2026, 3:04 PM CST
SHE:002252 Market Cap
SHE:002252 has a market cap or net worth of 30.19 billion as of July 10, 2026. Its market cap has decreased by -33.65% in one year.
Market Cap
30.19B
Enterprise Value
31.95B
Revenue
6.85B
Ranking
n/a
PE Ratio
22.64
Stock Price
4.58
Market Cap Chart
Since June 23, 2008, SHE:002252's market cap has increased from 2.48B to 30.19B, an increase of 1,116.15%. That is a compound annual growth rate of 14.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 30.19B | -27.89% |
| Dec 31, 2025 | 41.87B | -12.19% |
| Dec 20, 2024 | 47.69B | -10.30% |
| Dec 29, 2023 | 53.16B | 24.40% |
| Dec 30, 2022 | 42.74B | -7.04% |
| Dec 31, 2021 | 45.97B | -7.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharmaron Beijing | 52.08B |
| Sunshine Guojian Pharmaceutical (Shanghai) | 45.78B |
| Suzhou Zelgen Biopharmaceuticals | 36.23B |
| Beijing Wantai Biological Pharmacy Enterprise | 35.21B |
| Chongqing Zhifei Biological Products | 27.22B |
| Beijing Tiantan Biological Products | 23.35B |
| Hualan Biological Engineering | 23.08B |
| Xiamen Amoytop Biotech | 22.40B |